Eye drop recall, music by AI, climate report impact

Trouble viewing? View in your browser. View all Scientific American publications.

    

March 24, 2023

Pharmaceuticals Eye Drops Recalled after Deaths and Blindness--Here's What to Know Here’s how to tell whether your eye drops are safe to use and how to recognize a potential infection By Meghan Bartels

Artificial Intelligence Music-Making Artificial Intelligence is Getting Scary Good Google’s new AI model can generate entirely new music from text prompts. Here’s what they sound like. By Allison Parshall | 15:31

Climate Change IPCC Report Will Likely Shake Up U.N. Climate Talks Scientists say countries need to cut emissions far deeper to prevent catastrophic warming. That fact will hang over delegates when they meet later this year at the annual U.N. climate talks By Sara Schonhardt,E&E News

Pollution Scientists Look for Toxins from East Palestine Derailment in Ohio East Palestine residents are looking to independent researchers to fill gaps left by authorities about the toxic chemicals that could be affecting people after a train derailment By Mariana Lenharo,Nature magazine

Climate Change There Is Still Plenty We Can Do to Slow Climate Change While it may seem daunting, there are still many things we can do individually to slow climate change By Stephanie Roe

Astronomy Mysteriously Young 'Peekaboo' Galaxy Could Reveal Secrets of Early Universe A strange discovery could provide a window into the universe’s earliest galaxies By Allison Gasparini

FROM THE STORE Scientific American Volume 328, Issue 4

FROM THE ARCHIVE Bacteria Gang Together in Killer Biofilms, but Scientists Can Disrupt Gang Communications Biofilms—3-D mats of bacteria—kill as many people as cancer does and fight off antibiotics. Now scientists are turning biofilms’ own weapons against them By Karin Sauer | November 2017

WHAT WE'RE READING 'I'm Not a Doctor Just FYI': the Influencers Paid to Hawk Drugs on TikTok Many "patient influencers" offer medical advice without always revealing ties to pharmaceutical companies By Wilfred Chan | The Guardian | Mar. 17, 2023

LATEST ISSUES

Questions?   Comments?

Download the Scientific American App

To view this email as a web page, go here. You received this email because you opted-in to receive email from Scientific American. To ensure delivery please add news@email.scientificamerican.com to your address book. Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us